We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

20 hedge funds and large institutions have $32.8M invested in Aldeyra Therapeutics in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

48.78% more ownership

Funds ownership: 0% → 48.78% (+49%)

9% less funds holding

Funds holding: 22 → 20 (-2)

31% less capital invested

Capital invested by funds: $47.9M → $32.8M (-$15.1M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
6
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$73.8K
2
PVI
Pura Vida Investments
New York
+$64.1K
3
BFA
BlackRock Fund Advisors
California
+$39.5K
4
TRCT
Tower Research Capital (TRC)
New York
+$18.7K
5
Bank of America
Bank of America
North Carolina
+$11.7K

Top Sellers

Rank Fund Capital Flow
1
FMA
FNY Managed Accounts
New York
-$39.1K
2
AIC
AWM Investment Company
New York
-$30.5K
3
JP Morgan Chase
JP Morgan Chase
New York
-$11K
4
Morgan Stanley
Morgan Stanley
New York
-$8.67K
5
Millennium Management
Millennium Management
New York
-$18
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$10.4M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$9.62M – – –
AIC
3
AWM Investment Company
New York
$4.88M -$30.5K -5,200 -0.6%
SFM
4
Sphera Funds Management
Israel
$1.97M – – –
BC
5
Boxer Capital
California
$1.56M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$779K +$73.8K +12,586 +9%
BBA
7
Baker Bros. Advisors
New York
$760K – – –
KCM
8
Knoll Capital Management
Florida
$727K – – –
PVI
9
Pura Vida Investments
New York
$669K +$64.1K +10,933 +10%
Millennium Management
10
Millennium Management
New York
$535K -$18 -3 -0%
WMSA
11
Weiss Multi-Strategy Advisers
New York
$348K – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$283K – – –
BFA
13
BlackRock Fund Advisors
California
$146K +$39.5K +6,741 +33%
Northern Trust
14
Northern Trust
Illinois
$77K +$8.67K +1,478 +12%
Bank of America
15
Bank of America
North Carolina
$32K +$11.7K +2,000 +50%
TRCT
16
Tower Research Capital (TRC)
New York
$20K +$18.7K +3,181 +549%
Morgan Stanley
17
Morgan Stanley
New York
$16K -$8.67K -1,478 -33%
BA
18
BlackRock Advisors
Delaware
$16K – – –
BIM
19
BlackRock Investment Management
Delaware
$8K – – –
Manulife (Manufacturers Life Insurance)
20
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$5K – – –
FMA
21
FNY Managed Accounts
New York
– -$39.1K -5,000 Closed
JP Morgan Chase
22
JP Morgan Chase
New York
– -$11K -1,400 Closed

ALDX Hedge Fund Activity: Q4 2016 in Review

20 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q4 2016, worth a combined $32.8M — down 31% from $47.9M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ALDX and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 6 added.

The largest buyer was Vanguard Group, adding an estimated $73.8K. The largest seller was FNY Managed Accounts, exiting entirely with an estimated $39.1K sold.

  • 20 institutional investors held Aldeyra Therapeutics (ALDX) as of Q4 2016, down from 22 in Q3 2016.
  • Funds reported $32.8M of Aldeyra Therapeutics stock for Q4 2016, down 31% quarter-over-quarter.
  • 0 funds opened new Aldeyra Therapeutics positions in Q4 2016 and 2 closed out, a net change of -2 holders.
  • The largest Aldeyra Therapeutics buyer in Q4 2016 was Vanguard Group, an estimated $73.8K added.
  • The largest Aldeyra Therapeutics seller in Q4 2016 was FNY Managed Accounts, an estimated $39.1K sold.

Based on aggregated 13F filings for Q4 2016.